Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 7Hematologic Neoplasms 7Graft vs Host Disease 5Gliosarcoma 5Glioblastoma 5Brain Neoplasms 5Prostatic Neoplasms 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 4Waldenstrom Macroglobulinemia 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Oligodendroglioma 2Neurofibrosarcoma 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma 2Lung Neoplasms 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Glioma 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2

Interventions

Whole-Body Irradiation 4fludarabine 3Cyclophosphamide 3AP 1903 reagent 3fludarabine phosphate 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Alemtuzumab 2Thiotepa 1Sirolimus 1Pentostatin 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Flow Cytometry 1Drug Therapy 1Cytogenetic Analysis 1Cyclosporins 1Cyclosporine 1Busulfan 1Antilymphocyte Serum 111-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Anemia, Aplastic × Sirolimus × Clear all
NCT03192397 2026-04-14

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Roswell Park Cancer Institute

Phase 1/2 Active not recruiting
35 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡